Cell localisation of gadolinium-based nanoparticles and related radiosensitizing efficacy in glioblastoma cells
Cancer Nanotechnology, 2014, 5, 6.
L. Stefancikova, E. Porcel, P. Eustache, S. Li, D. Salaso, S. Marco, J.-L. Guerquin-Kern, M. Réfrégiers, O. Tillement, F. Lux, S. Lacombe
Advantages of gadolinium based ultrasmall nanoparticles vs molecular gadolinium chelates for radiotherapy guided by MRI for glioma treatment
Cancer Nanotechnology, 2014, 5, 4.
G. Le Duc, S. Roux, A. Paruta-Tuarez, S. Dufort, E. Brauer, A. Marais, C. Truillet, L. Sancey, P. Perriat, F. Lux, O. Tillement
Gadolinium-based nanoparticles to improve the hadrontherapy performances
Nanomedicine:NBM, 2014, 10, 1601-1608.
E. Porcel, O. Tillement, F. Lux, P. Mowat, N. Usami, K. Kobayashi, Y. Furusawa, C. Le Sech, S. Li, S. Lacombe
Targeting and in vivo imaging of non-small-cell lung cancer using nebulized multimodal contrast agents
PNAS, 2014, 111, 9247-9252.
A. Bianchi, S. Dufort, F. Lux, P.-Y. Fortin, N. Tassali, O. Tillement, J. –L. Coll, Y. Crémillieux
Radiation dose enhancement of gadolinium-based AGuIX nanoparticles on HeLa cells
Nanomedicine, 2014, 10, 1751-1755.
M. Luchette H. Korideck, M. Makrigiorgos, O. Tillement, R. Berbeco